Prevention of complications in type 2 diabetes: is drug glucose control evidence based?

PubWeight™: 0.75^‹?›

🔗 View Article (PMID 28126879)

Published in Br J Gen Pract on February 01, 2017

Authors

Rémy Boussageon¹, Denis Pouchain², Vincent Renard³

Author Affiliations

1: Department of General Practice, Faculté de Médecine de Poitiers, Scientific Committee of the French National College of Teachers in General Practice, Montreuil-sous-Bois, France.
2: Department of General Practice, Faculté de Médecine de Tours, Scientific Committee of the French National College of Teachers in General Practice, Montreuil-sous-Bois, France.
3: Department of General Practice, Faculté de Médecine de Paris-Est Créteil, Scientific Committee of the French National College of Teachers in General Practice, Montreuil-sous-Bois, France.

Articles cited by this ↗

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (1998) 95.79

Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med (2008) 47.90

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med (2008) 38.76

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ (2000) 35.06

Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med (2008) 25.70

Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med (2010) 10.75

Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. BMJ (2011) 5.77

Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials. BMJ (2011) 2.49

Effect of patients' risks and preferences on health gains with plasma glucose level lowering in type 2 diabetes mellitus. JAMA Intern Med (2014) 2.17

Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials. PLoS Med (2012) 1.85

Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial. Diabetologia (2009) 1.59

Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev (2012) 1.51

Effects of pharmacological treatments on micro- and macrovascular complications of type 2 diabetes: what is the level of evidence? Diabetes Metab (2014) 1.15

Is HbA1c a valid surrogate for macrovascular and microvascular complications in type 2 diabetes? Diabetes Metab (2015) 0.81